Back to Blog

AI-driven Advancements in Life Sciences

  • Blog

The momentum behind AI-driven advancements in life sciences has never been stronger, and this trend was spotlighted in Everest Group’s new 2025 PEAK Matrix® report, “Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment 2025.”

Trinity Life Sciences is honored to be recognized as a Leader in this comprehensive assessment, a distinction rooted in exceptional, tangible outcomes delivered for life sciences clients across the sector.

What Is the PEAK Matrix® Assessment? 

Everest Group’s PEAK Matrix® is a rigorous, comprehensive framework assessing the overall vision, capability, and market impact of platform providers. The 2025 report features detailed profiles and evaluations of 30 leading service providers. This research is grounded in an extensive annual Request For Information process (covering calendar year 2024), direct interactions with commercial life sciences providers, client reference checks, and ongoing tracking of the digital services market.

Why Trinity Was Named a Leader 

Our leadership position in the 2025 PEAK Matrix® Assessment reflects Trinity’s unwavering commitment to delivering value at every stage of the commercial lifecycle. Recognizing that every decision our clients make impacts a life, we lead with evidence-based solutions purpose-built for the unique needs of life sciences organizations. 

The growing emphasis on patient- and HCP-centricity to deliver superior customer experiences has modernized commercialization strategies, placing data, analytics, and AI at the core of life sciences enterprises’ go-to-market efforts. As a result, they are turning to strategic partners with domain-led digital expertise and scalable technology solutions to navigate the evolving landscape. Trinity Life Sciences’ generative and agentic AI investments, the TrinityEDGE suite of commercial solutions, its targeted domain-centric partnerships, and its thought leadership are augmented by its client flexibility and responsiveness. This focus has led to its recognition as a Leader in Everest Group’s Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment 2025.

—Durga Ambati, Practice Director at Everest Group

 

Transformative AI and Analytics in Action: Featured Case Studies 

A hallmark of the 2025 report is its spotlight on real, client-validated outcomes. Some highlights:

  • Faster Decision-Making with GenAI: For a rare-disease biotech, Trinity’s Brand Insights AI unlocked accessible, searchable data archives—speeding up strategic decision-making and reducing information silos. 
  • 10X ROI for Small Biopharma: Trinity enabled a small biopharma manufacturer to accelerate brand growth through an integrated, data-driven commercial strategy—achieving a tenfold return on investment with a 100-day acceleration plan. 
  • Informed Market Expansion: For a clinical-stage company, Trinity’s research and forecasts guided commercial resource allocation and expansion into additional patient populations. 
  • 20–30% Lift in Field Rep Productivity: At a midsize pharma company, Trinity’s AI-powered call planning dramatically boosted field force efficiency—reducing non-target calls by ~20% and increasing new-to-brand prescriptions. The client’s CEO recognized these advances in public communications. 

The Road Ahead: AI, Analytics, and Life Sciences Commercialization 

The industry’s shift toward patient- and HCP-centricity is reshaping commercialization strategies, driving demand for partners who blend domain expertise with scalable digital innovation. Trinity’s recognition as a Leader reflects our continuing investment in technology, data, and client-responsive solutions to help life sciences organizations compete and thrive in this evolving marketplace.

Want to Learn More? 

Trinity’s experts have created a library of thought leadership exploring the impact of GenAI and analytics on life sciences, featuring: 

Questions?

We’re here to help. Contact us. 

Disclaimer
Licensed extracts taken from Everest Group’s PEAK Matrix® Reports may be used by licensed third parties for use in their own marketing and promotional activities and collateral. Selected extracts from Everest Group’s PEAK Matrix® reports do not necessarily provide the full context of our research and analysis.  All research and analysis conducted by Everest Group’s analysts and included in Everest Group’s PEAK Matrix® reports is independent and no organization has paid a fee to be featured or to influence their ranking.  To access the complete research and to learn more about our methodology, please visit Everest Group PEAK Matrix® Reports. 

Back To Top